← Back to Search

Other

1 for Sickle Cell Anemia

Phase 1
Waitlist Available
Research Sponsored by GAAD Medical Research Institute Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
People with sickle cell disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 40 minutes
Awards & highlights

Study Summary

Most patients with sickle-cell disease have periodic intensely painful episodes. To manage this pain, we are proposing the drinking of at least 500 mL of water followed by far infrared radiation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~40 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 40 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Management

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Far Infrared Radiation

Find a Location

Who is running the clinical trial?

GAAD Medical Research Institute Inc.Lead Sponsor
21 Previous Clinical Trials
85 Total Patients Enrolled
Ken Nedd, M.D.Study ChairGAAD Medical Research Institute Inc.
19 Previous Clinical Trials
83 Total Patients Enrolled
Kwasi Donyina, Ph.D.Study DirectorGAAD Medical Research Institute Inc.
13 Previous Clinical Trials
44 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby May 2025